<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38383783</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>626</Volume><Issue>8001</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Prevalence of persistent SARS-CoV-2 in a large community surveillance study.</ArticleTitle><Pagination><StartPage>1094</StartPage><EndPage>1101</EndPage><MedlinePgn>1094-1101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-024-07029-4</ELocationID><Abstract><AbstractText>Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks<sup>1-5</sup>, give rise to highly divergent lineages<sup>6-8</sup> and contribute to cases with post-acute COVID-19 sequelae (long COVID)<sup>9,10</sup>. However, the population prevalence of persistent infections, their viral load kinetics and evolutionary dynamics over the course of infections remain largely unknown. Here, using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as 'persistent infections' as available evidence suggests that they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Individuals with persistent infection had more than 50% higher odds of self-reporting long COVID than individuals with non-persistent infection. We estimate that 0.1-0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, whereas others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies and/or are commonly found in immunocompromised people<sup>11-14</sup>. This work has profound implications for understanding and characterizing SARS-CoV-2 infection, epidemiology and evolution.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghafari</LastName><ForeName>Mahan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4123-3287</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2671-3864</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golubchik</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2765-9828</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Infectious Diseases Institute (Sydney ID), School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayoubkhani</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>House</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5835-8062</Identifier><AffiliationInfo><Affiliation>Department of Mathematics, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacIntyre-Cockett</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fryer</LastName><ForeName>Helen R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nurtay</LastName><ForeName>Anel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kemp</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0001-7077-6793</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferretti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7578-7301</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buck</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Angie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trebes</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3715-9109</Identifier><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazza</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lonie</LastName><ForeName>Lorne J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Studley</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rourke</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Darren L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashton</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6847-1525</Identifier><AffiliationInfo><Affiliation>The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crown</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5091-6282</Identifier><AffiliationInfo><Affiliation>The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCann</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Gregory R</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0001-5342-1421</Identifier><AffiliationInfo><Affiliation>The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Rui Andre Nunes Dos</ForeName><Initials>RAND</Initials><Identifier Source="ORCID">0000-0002-2070-5126</Identifier><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Zack</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5392-6558</Identifier><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Mohammad Adnan</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cahuantzi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Wellcome Sanger Institute COVID-19 Surveillance Team</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>COVID-19 Infection Survey Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>COVID-19 Genomics UK (COG-UK) Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1152-370X</Identifier><AffiliationInfo><Affiliation>Wellcome Sanger Institute, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2399-9657</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Sanger Institute, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonsall</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Ann Sarah</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Clinical Trials Unit at UCL, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lythgoe</LastName><ForeName>Katrina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7089-7680</Identifier><AffiliationInfo><Affiliation>Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="Y">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088562" MajorTopicYN="Y">Persistent Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012641" MajorTopicYN="N">Selection, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38383783</ArticleId><ArticleId IdType="pmc">PMC10901734</ArticleId><ArticleId IdType="doi">10.1038/s41586-024-07029-4</ArticleId><ArticleId IdType="pii">10.1038/s41586-024-07029-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dennehy JJ, Gupta RK, Hanage WP, Johnson MC, Peacock TP. Where is the next SARS-CoV-2 variant of concern? Lancet. 2022;399:1938&#x2013;1939. doi: 10.1016/S0140-6736(22)00743-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00743-7</ArticleId><ArticleId IdType="pmc">PMC9119661</ArticleId><ArticleId IdType="pubmed">35598619</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto SP, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr. Biol. 2021;31:R918&#x2013;R929. doi: 10.1016/j.cub.2021.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2021.06.049</ArticleId><ArticleId IdType="pmc">PMC8220957</ArticleId><ArticleId IdType="pubmed">34314723</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Reiche, A. S. et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat. Commun.14, 3235 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10239218</ArticleId><ArticleId IdType="pubmed">37270625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill V, et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus Evol. 2022;8:veac080. doi: 10.1093/ve/veac080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac080</ArticleId><ArticleId IdType="pmc">PMC9752794</ArticleId><ArticleId IdType="pubmed">36533153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari, M., Liu, Q., Dhillon, A., Katzourakis, A. &amp; Weissman, D. B. Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern. Front. Virol.10.3389/fviro.2022.942555 (2022).</Citation></Reference><Reference><Citation>Choi B, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 2020;383:2291&#x2013;2293. doi: 10.1056/NEJMc2031364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp SA, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277&#x2013;282. doi: 10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaguza, C. et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection. Cell Rep. Med.4, 100943 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906997</ArticleId><ArticleId IdType="pubmed">36791724</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank, Z. et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis.10.1093/cid/ciac722 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182:1295&#x2013;1310.e20. doi: 10.1016/j.cell.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7418704</ArticleId><ArticleId IdType="pubmed">32841599</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy KR, et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021;371:1139&#x2013;1142. doi: 10.1126/science.abf6950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf6950</ArticleId><ArticleId IdType="pmc">PMC7971772</ArticleId><ArticleId IdType="pubmed">33536258</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari S, et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat. Med. 2022;28:1501&#x2013;1508. doi: 10.1038/s41591-022-01882-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01882-4</ArticleId><ArticleId IdType="pmc">PMC9307477</ArticleId><ArticleId IdType="pubmed">35725921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson SAJ, et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol. 2022;8:veac050. doi: 10.1093/ve/veac050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac050</ArticleId><ArticleId IdType="pmc">PMC9384748</ArticleId><ArticleId IdType="pubmed">35996593</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virologicalhttps://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).</Citation></Reference><Reference><Citation>Avanzato VA, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183:1901&#x2013;1912.e9. doi: 10.1016/j.cell.2020.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.049</ArticleId><ArticleId IdType="pmc">PMC7640888</ArticleId><ArticleId IdType="pubmed">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cele S, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30:154&#x2013;162.e5. doi: 10.1016/j.chom.2022.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8758318</ArticleId><ArticleId IdType="pubmed">35120605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussenblatt V, et al. Yearlong COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B-cell depletion. J. Infect. Dis. 2022;225:1118&#x2013;1123. doi: 10.1093/infdis/jiab622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab622</ArticleId><ArticleId IdType="pmc">PMC8755281</ArticleId><ArticleId IdType="pubmed">34940844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lythgoe KA, et al. SARS-CoV-2 within-host diversity and transmission. Science. 2021;372:eabg0821. doi: 10.1126/science.abg0821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg0821</ArticleId><ArticleId IdType="pmc">PMC8128293</ArticleId><ArticleId IdType="pubmed">33688063</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun KM, et al. Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks. PLoS Pathog. 2021;17:e1009849. doi: 10.1371/journal.ppat.1009849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009849</ArticleId><ArticleId IdType="pmc">PMC8412271</ArticleId><ArticleId IdType="pubmed">34424945</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouwels KB, et al. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health. 2021;6:e30&#x2013;e38. doi: 10.1016/S2468-2667(20)30282-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30282-6</ArticleId><ArticleId IdType="pmc">PMC7786000</ArticleId><ArticleId IdType="pubmed">33308423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lythgoe, K. et al. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey. Proc. R. Soc. B.290, 20231284 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10581763</ArticleId><ArticleId IdType="pubmed">37848057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissler SM, et al. Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons. N. Engl. J. Med. 2021;385:2489&#x2013;2491. doi: 10.1056/NEJMc2102507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2102507</ArticleId><ArticleId IdType="pmc">PMC8693673</ArticleId><ArticleId IdType="pubmed">34941024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones TC, et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373:eabi5273. doi: 10.1126/science.abi5273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi5273</ArticleId><ArticleId IdType="pmc">PMC9267347</ArticleId><ArticleId IdType="pubmed">34035154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodcroft, E. B. CoVariants: SARS-CoV-2 mutations and variants of interest. CoVariantshttps://covariants.org/ (2021).</Citation></Reference><Reference><Citation>Cox M, et al. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol. 2023;21:112&#x2013;124. doi: 10.1038/s41579-022-00809-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00809-7</ArticleId><ArticleId IdType="pmc">PMC9616429</ArticleId><ArticleId IdType="pubmed">36307535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J-W, et al. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe. 2021;29:489&#x2013;502.e8. doi: 10.1016/j.chom.2021.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.01.015</ArticleId><ArticleId IdType="pmc">PMC7846228</ArticleId><ArticleId IdType="pubmed">33548198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira F. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene. Infect. Genet. Evol. 2020;85:104525. doi: 10.1016/j.meegid.2020.104525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104525</ArticleId><ArticleId IdType="pmc">PMC7467077</ArticleId><ArticleId IdType="pubmed">32890763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom, J. D. &amp; Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol.9, vead055 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10506532</ArticleId><ArticleId IdType="pubmed">37727875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson, T. et al. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes. Nature623, 594&#x2013;600 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10651478</ArticleId><ArticleId IdType="pubmed">37748513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallichotte EN, et al. Early adoption of longitudinal surveillance for SARS-CoV-2 among staff in long-term care facilities: prevalence, virologic and sequence analysis. Microbiol. Spectr. 2021;9:e0100321. doi: 10.1128/Spectrum.01003-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.01003-21</ArticleId><ArticleId IdType="pmc">PMC8579921</ArticleId><ArticleId IdType="pubmed">34756092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakki S, et al. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. Lancet Respir. Med. 2022;10:1061&#x2013;1073. doi: 10.1016/S2213-2600(22)00226-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00226-0</ArticleId><ArticleId IdType="pmc">PMC9388060</ArticleId><ArticleId IdType="pubmed">35988572</ArticleId></ArticleIdList></Reference><Reference><Citation>Viloria Winnett A, et al. Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods. PNAS Nexus. 2023;2:gad033. doi: 10.1093/pnasnexus/pgad033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad033</ArticleId><ArticleId IdType="pmc">PMC10013338</ArticleId><ArticleId IdType="pubmed">36926220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom MR, Mina MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin. Infect. Dis. 2020;71:2252&#x2013;2254. doi: 10.1093/cid/ciaa619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa619</ArticleId><ArticleId IdType="pmc">PMC7314112</ArticleId><ArticleId IdType="pubmed">32435816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay JA, et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science. 2021;373:eabh0635. doi: 10.1126/science.abh0635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh0635</ArticleId><ArticleId IdType="pmc">PMC8527857</ArticleId><ArticleId IdType="pubmed">34083451</ArticleId></ArticleIdList></Reference><Reference><Citation>Fryer HR, et al. Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias. PLoS Pathog. 2023;19:e1011461. doi: 10.1371/journal.ppat.1011461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011461</ArticleId><ArticleId IdType="pmc">PMC10449197</ArticleId><ArticleId IdType="pubmed">37578971</ArticleId></ArticleIdList></Reference><Reference><Citation>Owusu D, et al. Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19. J. Infect. Dis. 2021;224:1362&#x2013;1371. doi: 10.1093/infdis/jiab107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab107</ArticleId><ArticleId IdType="pmc">PMC7989388</ArticleId><ArticleId IdType="pubmed">33649773</ArticleId></ArticleIdList></Reference><Reference><Citation>Munker D, et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur. Respir. J. 2021;58:2002724. doi: 10.1183/13993003.02724-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02724-2020</ArticleId><ArticleId IdType="pmc">PMC7898160</ArticleId><ArticleId IdType="pubmed">33602859</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthikeyan S, et al. Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission. Nature. 2022;609:101&#x2013;108. doi: 10.1038/s41586-022-05049-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05049-6</ArticleId><ArticleId IdType="pmc">PMC9433318</ArticleId><ArticleId IdType="pubmed">35798029</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafer, M. M. et al. Human origin ascertained for SARS-CoV-2 Omicron-like spike sequences detected in wastewater: a targeted surveillance study of a cryptic lineage in an urban sewershed. Preprint at medRxivhttps://www.medrxiv.org/content/10.1101/2022.10.28.22281553v5 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.28.22281553v5</ArticleId><ArticleId IdType="pmc">PMC11049544</ArticleId><ArticleId IdType="pubmed">38484748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay JA, et al. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study. eLife. 2022;11:e81849. doi: 10.7554/eLife.81849.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.81849</ArticleId><ArticleId IdType="pmc">PMC9711520</ArticleId><ArticleId IdType="pubmed">36383192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M-J, et al. Persistent SARS-CoV-2 infection in asymptomatic young adults. Signal Transduct. Target. Ther. 2022;7:77. doi: 10.1038/s41392-022-00931-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00931-1</ArticleId><ArticleId IdType="pmc">PMC8905556</ArticleId><ArticleId IdType="pubmed">35264553</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam JRC, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022;376:eabn4947. doi: 10.1126/science.abn4947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn4947</ArticleId><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet. 2023;401:833&#x2013;842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat. Methods. 2021;18:449&#x2013;453. doi: 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. 2023;95:e28364. doi: 10.1002/jmv.28364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffia-Bizzozero S, et al. Viable SARS-CoV-2 Omicron sub-variants isolated from autopsy tissues. Front. Microbiol. 2023;14:1192832. doi: 10.3389/fmicb.2023.1192832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1192832</ArticleId><ArticleId IdType="pmc">PMC10240073</ArticleId><ArticleId IdType="pubmed">37283920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Zhao H, Esp&#xed;n E, Tebbutt SJ. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir. Med. 2023;11:504&#x2013;506. doi: 10.1016/S2213-2600(23)00142-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00142-X</ArticleId><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Vihta KD, et al. Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom. Clin. Infect. Dis. 2022;75:e329&#x2013;e337. doi: 10.1093/cid/ciab945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab945</ArticleId><ArticleId IdType="pmc">PMC8767848</ArticleId><ArticleId IdType="pubmed">34748629</ArticleId></ArticleIdList></Reference><Reference><Citation>COG-UK. COG-UK publication. Protocols.iohttps://www.protocols.io/workspaces/coguk/publications (2020).</Citation></Reference><Reference><Citation>Connor Lab. ncov2019-artic-nf. GitHubhttps://github.com/connor-lab/ncov2019-artic-nf (2020).</Citation></Reference><Reference><Citation>Bonsall D, et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in low-income settings. J. Clin. Microbiol. 2020;58:e00382-20. doi: 10.1128/JCM.00382-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00382-20</ArticleId><ArticleId IdType="pmc">PMC7512176</ArticleId><ArticleId IdType="pubmed">32669382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wymant C, et al. Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver. Virus Evol. 2018;4:vey007. doi: 10.1093/ve/vey007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vey007</ArticleId><ArticleId IdType="pmc">PMC5961307</ArticleId><ArticleId IdType="pubmed">29876136</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh BQ, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 2020;37:1530&#x2013;1534. doi: 10.1093/molbev/msaa015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa015</ArticleId><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang DT, Chernomor O, von Haeseler A, Minh BQ, Vinh LS. UFBoot2: improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 2018;35:518&#x2013;522. doi: 10.1093/molbev/msx281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msx281</ArticleId><ArticleId IdType="pmc">PMC5850222</ArticleId><ArticleId IdType="pubmed">29077904</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) Virus Evol. 2016;2:vew007. doi: 10.1093/ve/vew007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vew007</ArticleId><ArticleId IdType="pmc">PMC4989882</ArticleId><ArticleId IdType="pubmed">27774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Smith DK, Tsan-Yuk ZHL. ggtree: An R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 2017;8:28&#x2013;36. doi: 10.1111/2041-210X.12628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2041-210X.12628</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples) Biometrika. 1965;52:591&#x2013;611. doi: 10.1093/biomet/52.3-4.591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/52.3-4.591</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br. J. Gen. Pract. 2021;71:e806&#x2013;e814. doi: 10.3399/BJGP.2021.0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Genomics UK (COG-UK) Consortium. An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe. 2020;1:e99&#x2013;e100. doi: 10.1016/S2666-5247(20)30054-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30054-9</ArticleId><ArticleId IdType="pmc">PMC7266609</ArticleId><ArticleId IdType="pubmed">32835336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>